{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:34:45Z","timestamp":1790606085885,"version":"4.1.0"},"reference-count":16,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pulmonary hypertension (PH) is recognized as a pathophysiological disorder encompassing a wide spectrum of clinical conditions related to various cardiovascular and respiratory diseases [...]<\/jats:p>","DOI":"10.3390\/ijms25021166","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:50:56Z","timestamp":1705549856000},"page":"1166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pathophysiology and Treatment of Pulmonary Arterial Hypertension"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-109X","authenticated-orcid":false,"given":"Yoshihiro","family":"Fukumoto","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","article-title":"Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017\/JPCPHS 2017)","volume":"83","author":"Fukuda","year":"2019","journal-title":"Circ. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1253\/circj.CJ-11-0741","article-title":"Pulmonary artery distensibility index is a non-invasive useful marker of pulmonary arterial hypertension progression","volume":"75","author":"Fukumoto","year":"2011","journal-title":"Circ. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1253\/circj.CJ-11-0473","article-title":"Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"75","author":"Fukumoto","year":"2011","journal-title":"Circ. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1253\/circj.CJ-13-1016","article-title":"Histopathological examination by lung biopsy for the evaluation of operability and postoperative prognosis in patients with chronic thromboembolic pulmonary hypertension","volume":"78","author":"Yamaki","year":"2014","journal-title":"Circ. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv736","article-title":"Optical frequency-domain imaging and pulmonary angioscopy in chronic thromboembolic pulmonary hypertension","volume":"37","author":"Chibana","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"30","article-title":"Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension","volume":"17","author":"Chibana","year":"2017","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1253\/circj.CJ-11-1217","article-title":"Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension","volume":"76","author":"Sugimura","year":"2012","journal-title":"Circ. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15910","DOI":"10.3390\/ijms232415910","article-title":"CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension","volume":"23","author":"Tomaszewski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tornling, G., Batta, R., Salvail, D., Raud, J., and Denton, C.P. (2023). Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087478"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Peng, Y., Dai, J., and Zhao, Y.Y. (2023). Egln1Tie2Cre Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1Tie2Cre Mice as a Useful PAH Model. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032391"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ryanto, G.R.T., Musthafa, A., Hara, T., and Emoto, N. (2023). Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043332"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pullamsetti, S.S., Sitapara, R., Osterhout, R., Weiss, A., Carter, L.L., Zisman, L.S., and Schermuly, R.T. (2023). Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612653"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Otani, N., Watanabe, R., Tomoe, T., Toyoda, S., Yasu, T., and Nakamoto, T. (2023). Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043979"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nakashima, N., Tahara, N., Sugiyama, Y., Bekki, M., Maeda-Ogata, S., Honda, A., Goto, C., Tanaka, S., and Fukumoto, Y. (2023). Compression Stockings Improve Lower Legs Symptom in Patients with Pulmonary Artery Hypertension Treated by Pulmonary Vasodilators-A Pilot Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072484"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/cjpp-2019-0663","article-title":"Long-term survival outcome for pre-capillary pulmonary hypertension at a Japanese single center","volume":"98","author":"Sugiyama","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:23Z","timestamp":1760104163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/1166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25021166"],"URL":"https:\/\/doi.org\/10.3390\/ijms25021166","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}